These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 28959274)
21. Publication selection in health policy research: the winner's curse hypothesis. Costa-Font J; McGuire A; Stanley T Health Policy; 2013 Jan; 109(1):78-87. PubMed ID: 23182564 [TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner's curse. Nakaoka H; Inoue I J Hum Genet; 2009 Nov; 54(11):615-23. PubMed ID: 19851339 [TBL] [Abstract][Full Text] [Related]
23. Power estimation and sample size determination for replication studies of genome-wide association studies. Jiang W; Yu W BMC Genomics; 2016 Jan; 17 Suppl 1(Suppl 1):3. PubMed ID: 26818952 [TBL] [Abstract][Full Text] [Related]
24. PON1 Q192R and clopidogrel: a case of the winner's curse or inadequate replication? Talameh JA; McLeod HL Clin Pharmacol Ther; 2011 Dec; 90(6):771-4. PubMed ID: 22089342 [TBL] [Abstract][Full Text] [Related]
25. Selection-adjusted inference: an application to confidence intervals for cis-eQTL effect sizes. Panigrahi S; Zhu J; Sabatti C Biostatistics; 2021 Jan; 22(1):181-197. PubMed ID: 31301173 [TBL] [Abstract][Full Text] [Related]
26. Selective peak inference: Unbiased estimation of raw and standardized effect size at local maxima. Davenport S; Nichols TE Neuroimage; 2020 Apr; 209():116375. PubMed ID: 31866164 [TBL] [Abstract][Full Text] [Related]
27. The value of victory: social origins of the winner's curse in common value auctions. van den Bos W; Li J; Lau T; Maskin E; Cohen JD; Montague PR; McClure SM Judgm Decis Mak; 2008 Oct; 3(7):483-492. PubMed ID: 20305741 [TBL] [Abstract][Full Text] [Related]
28. Analysis of independent cohorts of outbred CFW mice reveals novel loci for behavioral and physiological traits and identifies factors determining reproducibility. Zou J; Gopalakrishnan S; Parker CC; Nicod J; Mott R; Cai N; Lionikas A; Davies RW; Palmer AA; Flint J G3 (Bethesda); 2022 Jan; 12(1):. PubMed ID: 34791208 [TBL] [Abstract][Full Text] [Related]
29. The power of numbers. Dauriz M; Meigs JB Diabetologia; 2016 Jul; 59(7):1400-1402. PubMed ID: 27115413 [No Abstract] [Full Text] [Related]
31. Beyond Rare-Variant Association Testing: Pinpointing Rare Causal Variants in Case-Control Sequencing Study. Lin WY Sci Rep; 2016 Feb; 6():21824. PubMed ID: 26903168 [TBL] [Abstract][Full Text] [Related]
32. Peril beyond the winner's curse: A small sample size is the bane of biomarker discovery. Thambisetty M; Casanova R; Varma S; Legido Quigley C Alzheimers Dement; 2017 May; 13(5):606-607. PubMed ID: 28119051 [No Abstract] [Full Text] [Related]
33. A multistep approach to single nucleotide polymorphism-set analysis: an evaluation of power and type I error of gene-based tests of association after pathway-based association tests. Valcarcel A; Grinde K; Cook K; Green A; Tintle N BMC Proc; 2016; 10(Suppl 7):349-355. PubMed ID: 27980661 [TBL] [Abstract][Full Text] [Related]
34. GWAS to Sequencing: Divergence in Study Design and Analysis. King CR; Nicolae DL Genes (Basel); 2014 May; 5(2):460-76. PubMed ID: 24879455 [TBL] [Abstract][Full Text] [Related]
35. The genetics of drug-related movement disorders, an umbrella review of meta-analyses. van der Burg NC; Al Hadithy AFY; van Harten PN; van Os J; Bakker PR Mol Psychiatry; 2020 Oct; 25(10):2237-2250. PubMed ID: 32020047 [TBL] [Abstract][Full Text] [Related]
37. A general method for combining different family-based rare-variant tests of association to improve power and robustness of a wide range of genetic architectures. Green A; Cook K; Grinde K; Valcarcel A; Tintle N BMC Proc; 2016; 10(Suppl 7):165-170. PubMed ID: 27980630 [TBL] [Abstract][Full Text] [Related]
38. Flexible design for following up positive findings. Yu K; Chatterjee N; Wheeler W; Li Q; Wang S; Rothman N; Wacholder S Am J Hum Genet; 2007 Sep; 81(3):540-51. PubMed ID: 17701899 [TBL] [Abstract][Full Text] [Related]
39. Vincristine pharmacogenomics: 'winner's curse' or a different phenotype? Diouf B; Crews KR; Evans WE Pharmacogenet Genomics; 2016 Feb; 26(2):51-2. PubMed ID: 26704670 [No Abstract] [Full Text] [Related]
40. Assessing risk factors with information beyond P value thresholds: Statistical significance does not equal clinical importance. Putt ME Cancer; 2021 Apr; 127(8):1180-1185. PubMed ID: 33351186 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]